Prolonging parathyroid hormone analog action in vitro and in vivo through peptide lipidation
Abstract Parathyroid hormone (PTH) analogs with improved actions in vivo could lead to optimized treatments for bone and mineral ion diseases. Rapid clearance from the circulation and short dwell times on the PTH receptor limit the efficacies of conventional PTH peptides currently in medical use. He...
Saved in:
| Main Authors: | Jakob Höppner, Hiroshi Noda, Anju Krishnan Anitha, Ross W. Cheloha, Thomas Dean, Michael Bruce, Daniel J. Brooks, Michael Mannstadt, Mary L. Bouxsein, Samuel H. Gellman, Ashok Khatri, Harald Jüppner, Thomas J. Gardella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-59665-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human diseases caused by homozygous PTH1R mutations
by: Ignacio Portales-Castillo, et al.
Published: (2025-08-01) -
Giant Parathyroid Tumor: Parathyroid Adenoma versus Parathyroid Carcinoma
by: Farid Gossili, et al.
Published: (2022-01-01) -
Towards Neural‐Network‐Based Optical Temperature Sensing of Semiconductor Membrane External Cavity Laser
by: Jakob Mannstadt, et al.
Published: (2025-08-01) -
Parathyroid Hormone Fluctuations During Thyroid and Parathyroid Surgery
by: Emily S. Sagalow, et al.
Published: (2025-01-01) -
Parathyroid carcinoma
by: Filipović Aleksandar, et al.
Published: (2006-01-01)